Back to Search
DR. PETER C EARL MD
MD
Obstetrics & Gynecology Physician
NPI: 1740256478IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
MD43527(TN)0101-230521(VA)
Education
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER
Class of 1984
Research & Publications (20)
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity.
PMID 19450644·Vaccine·2009
2-rct
Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.
PMID 19135115·Vaccine·2009
7-preclinical
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.
PMID 19654066·Vaccine·2009
7-preclinical
Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection.
PMID 19420086·J Virol·2009
8-other
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.
PMID 18808335·J Infect Dis·2008
3-trial
Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006.
PMID 18650362·J Clin Microbiol·2008
8-other
Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.
PMID 18155813·Vaccine·2008
7-preclinical
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
PMID 18678911·Proc Natl Acad Sci U S A·2008
4-observational
Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.
PMID 18048074·Virology·2008
7-preclinical
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.
PMID 17977963·J Virol·2008
4-observational
Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.
PMID 18524827·J Virol·2008
7-preclinical
Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.
PMID 17581986·J Virol·2007
7-preclinical
Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges.
PMID 17229505·Vaccine·2007
7-preclinical
A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice.
PMID 17579577·Mol Ther·2007
7-preclinical
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
PMID 17507071·Virology·2007
7-preclinical
Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.
PMID 17499326·Virology·2007
7-preclinical
Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine.
PMID 16740288·Virology·2006
7-preclinical
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.
PMID 16436502·Proc Natl Acad Sci U S A·2006
7-preclinical
The association of Aedes aegypti and Ae. albopictus in Allende, Nuevo León, Mexico.
PMID 16646314·J Am Mosq Control Assoc·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via 1101 Wilson Blvd · 3 locations total
- Address
- 1101 WILSON BLVD
ARLINGTON, VA 22209 - Phone
- (888) 731-8994
Quick Facts
- NPI
- 1740256478
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile